Exhibit 99.2
Abbreviated Quarterly Report
On Behalf of Funding Trust 2012-1
For the fiscal quarter ending March 31, 2013
Prepared: June 13, 2013
Table of Contents
| Obligor Credit Information |
2 | |||
| Loan Information |
3 |
Attached:
Monthly Servicer Reports for the three collection periods ending March 4, 2013
Obligor Credit Information
| Data as of 3-31-13 | ||||||||||||||||||||||||||||||||||||||||||
| Obligor CODE |
Industry Sector | SubSector | Credit Score at Closing |
Current Credit Score |
Investment Stage at Closing |
Current Stage (as defined by equity round raised/Public/Other (LMM) |
Equity Raised to Date |
Current Valuation ($mm) Post Money (Private), Market Cap (Public), EV (Other) |
Statement Date | Period | LTM Revenues (All Obligors, $000s) |
Total Senior Debt (All Obligors, $000s) |
TTM/Annualized EBITDA |
|||||||||||||||||||||||||||||
| OBLIGOR #1 |
Pharmaceuticals | Drug Delivery | 2 | 2 | Public | Public | 156,676,000 | 331.8 | 3/31/2013 | LTM | 3,005 | 14,210 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #2 |
Pharmaceuticals | Drug Delivery | 2 | 1 | Public | Public | 337,843,000 | 75.3 | 3/31/2013 | LTM | 2,915 | 4,873 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #3 |
Clean Tech | Clean Tech | 2 | 2 | Public | Public | 913,110,000 | 180.1 | 3/31/2013 | LTM | 87,577 | 18,016 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #4 |
Pharmaceuticals | Drug Discovery & Development | 2 | 1 | Public | Public | 301,180,000 | 87.0 | 3/31/2013 | LTM | — | 18,390 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #5 |
Pharmaceuticals | Drug Discovery & Development | 2 | 2 | Public | Public | 439,173,000 | 121.3 | 3/31/2013 | LTM | 18,749 | 26,390 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #6 |
Technology | Software | 1 | 1 | Series E | Series E | 283,423,566 | 1,228.0 | 3/31/2013 | LTM | 69,250 | 30,800 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #7 |
Pharmaceuticals | Drug Discovery & Development | 1 | 1 | Public | Public | 179,986,460 | 168.1 | 3/31/2013 | LTM | — | 10,000 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #8 |
Pharmaceuticals | Drug Discovery & Development | 2 | 2 | Public | Public | 119,740,000 | 253.0 | 3/31/2013 | LTM | — | 14,280 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #9 |
Pharmaceuticals | Biotechnology Tools | 1 | N/A- Paid Off | Series A | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | |||||||||||||||||||||||||||||
| OBLIGOR #10 |
Technology | Information Services | 3 | 4 | Series A | Series A | 7,739,904 | 21.5 | 3/31/2013 | LTM | 1,212 | 2,380 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #11 |
Clean Tech | Clean Tech | 2 | 1 | Public | Public | 185,670,000 | 255.58 | 3/31/2013 | LTM | 220,039 | 10,490 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #12 |
Clean Tech | Clean Tech | 2 | 2 | Series C | Series C | 46,518,489 | 153.2 | 3/31/2013 | LTM | 2,510 | 7,757 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #13 |
Pharmaceuticals | Drug Discovery & Development | 1 | 1 | Public | Public | 455,725,000 | 236.4 | 3/31/2013 | LTM | — | 19,520 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #14 |
Pharmaceuticals | Drug Delivery | 1 | 1 | Series B | Series B | 17,319,335 | 45.4 | 3/31/2013 | LTM | 39,979 | 15,000 | NA | |||||||||||||||||||||||||||||
| OBLIGOR #15 |
Medical Device | Biotechnology Tools | 2 | 2 | Series C | Series D | 53,849,310 | 85.6 | 3/31/2013 | LTM | 24,043 | 5,308 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #16 |
Technology | Communications & Networking | 3 | 3 | Series E | Series E | 123,900,000 | 485.0 | 3/31/2013 | LTM | 166,423 | 21 | (25,128 | ) | ||||||||||||||||||||||||||||
| OBLIGOR #17 |
Medical Device | Therapeutic | 2 | 3 | Series C | Series C | 59,827,598 | 81.8 | 3/31/2013 | LTM | 14 | 23 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #18 |
Technology | Internet Consumer & Business Services |
2 | 2 | Series C | Series C | 45,311,779 | 193.8 | 3/31/2013 | LTM | 65,313 | 16,549 | 8,745 | |||||||||||||||||||||||||||||
| OBLIGOR #19 |
Pharmaceuticals | Diagnostic | 2 | 3 | Series E | Series E | 148,108,419 | 103.0 | 3/31/2013 | LTM | 13,687 | 10,000 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #20 |
Medical Device | Surgical Devices | 2 | 2 | Series C | Series D | 75,306,027 | 77.9 | 3/31/2013 | LTM | 5,644 | 7,191 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #21 |
Technology | Internet Consumer & Business Services |
1 | 1 | Public | Public | 200,320,000 | 867.7 | 3/31/2013 | LTM | 79,925 | 9,941 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #22 |
Medical Device | Medical Device & Equipment | 2 | 2 | Series G | Series G | 48,889,757.0 | 68.9 | 3/31/2013 | LTM | 9,413 | 9,170 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #23 |
Technology | Internet Consumer & Business Services |
2 | 2 | Series B | Series B | 27,018,085 | 41.3 | 3/31/2013 | LTM | 26,065 | 11,107 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #24 |
Middle Market | Media/Content/Info | 2 | 2 | Other | Other | 43,697,000 | 68.2 | 3/31/2013 | LTM | 91,185 | 27,546 | 10,656 | |||||||||||||||||||||||||||||
| OBLIGOR #25 |
Middle Market | Internet Consumer & Business Services |
2 | 2 | Other | Other | 12,188,332 | 24.8 | 3/31/2013 | LTM | 16,767 | 14,862 | 4,385 | |||||||||||||||||||||||||||||
Page 2
Loan Information as of March 31, 2013
| Per LSA | ||||||||||||||||||||||||||
| Obligor CODE |
Status (Active - Initial Pool, Active - Substitute) |
Date of Substitution(1) | Cash Yield | Fixed / Floating | Loan Status (Current, Delinquent, Defaulted, Prepaid, Repaid, Repurchased, Substituted) |
Prepayment Date | Prepayment Amount (Principal + Final Payment + Prepayment Penalty + Success Fee) |
Date of Payment Default | Days Past Due | |||||||||||||||||
| OBLIGOR #1 |
Active - Initial Pool | 8.50 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #2 |
Active - Initial Pool | (4/3/2013 | ) | 10.75 | % | Floating | Current | |||||||||||||||||||
| OBLIGOR #3 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #4 |
Active - Initial Pool | (4/3/2013 | ) | 10.55 | % | Floating | Current | |||||||||||||||||||
| OBLIGOR #5 |
Active - Initial Pool | 11.90 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #6 |
Active - Initial Pool | 8.88 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #7 |
Active - Initial Pool | 9.55 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #8 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #9 |
Active - Initial Pool | 13.50 | % | Floating | Prepaid | 12/10/2013 | $ | 3,909,219 | ||||||||||||||||||
| OBLIGOR #10 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #11 |
Active - Initial Pool | 9.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #12 |
Active - Initial Pool | 10.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #13 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #14 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #15 |
Active - Initial Pool | 9.95 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #16 |
Active - Initial Pool | 12.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #17 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #18 |
Active - Initial Pool | 10.13 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #18 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #19 |
Active - Initial Pool | 11.65 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #20 |
Active - Initial Pool | 12.95 | % | Fixed | Current | |||||||||||||||||||||
| OBLIGOR #21 |
Active - Initial Pool | 6.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #21 |
Active - Initial Pool | 8.75 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #22 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #23 |
Active - Initial Pool | 9.50 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #24 |
Active - Initial Pool | (5/29/2013 | ) | 10.00 | % | Floating | Current | |||||||||||||||||||
| OBLIGOR #25 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #25 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||||||
| (1) | Further information regarding the substitutions of Obligor #2, #4 and #24 will be reflected in the second quarterly servicing report as well as the monthly servicing reports issued for April, May and June of FY 2013. |
Page 3
Abbreviated Quarterly Report
On Behalf of Funding Trust 2012-1
For the fiscal quarter ending June 30, 2013
Prepared: September 12, 2013
Table of Contents
| Obligor Credit Information |
2 | |||
| Loan Information |
3 |
Attached:
Monthly Servicer Reports for the three collection periods ending June 4, 2013
Obligor Credit Information
| Data as of 6-30-13 | ||||||||||||||||||||||||||||||||||||||||
| Obligor CODE |
Industry Sector | Credit Score at Closing |
Current Credit Score |
Investment Stage at Closing |
Current Stage (as defined by equity round raised/Public/Other (LMM) |
Equity Raised to Date |
Current Valuation ($mm) Post Money (Private), Market Cap (Public), EV (Other) |
Statement Date | Period | LTM Revenues (All Obligors, $000s) |
Total Senior Debt (All Obligors, $000s) |
TTM/Annualized EBITDA |
||||||||||||||||||||||||||||
| OBLIGOR #1 |
Pharmaceuticals | 2 | 2 | Public | Public | 158,278,000 | 347.0 | 6/30/2013 | LTM | 3,188 | 12.39 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #2 |
Pharmaceuticals | 2 | N/A- Paid Off | Public | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | ||||||||||||||||||||||||||||
| OBLIGOR #3 |
Clean Tech | 2 | 2 | Public | Public | 928,417,000 | 138.4 | 6/30/2013 | LTM | 81,789 | 35.00 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #4 |
Pharmaceuticals | 2 | N/A- Paid Off | Public | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | ||||||||||||||||||||||||||||
| OBLIGOR #5 |
Pharmaceuticals | 2 | 2 | Public | Public | 495,199,000 | 128.6 | 6/30/2013 | LTM | 17,196 | 23.89 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #6 |
Technology | 1 | 1 | Series E | Series E | 283,423,566 | 1,228.0 | 6/30/2013 | LTM | 83,766 | 30.76 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #7 |
Pharmaceuticals | 1 | 1 | Public | Public | 2,345,954,000 | 257.8 | 6/30/2013 | LTM | 4,568 | 15.00 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #8 |
Pharmaceuticals | 2 | 2 | Public | Public | 152,270,000 | 254.6 | 6/30/2013 | LTM | — | 14.77 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #9 |
Pharmaceuticals | 1 | N/A- Paid Off | Series A | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | ||||||||||||||||||||||||||||
| OBLIGOR #10 |
Technology | 3 | 4 | Series A | Series B | 7,994,211 | 21.5 | 6/30/2013 | LTM | 1,264 | 0.90 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #11 |
Clean Tech | 2 | 1 | Public | Public | 188,082,000 | 295.8 | 6/30/2013 | LTM | 222,125 | 9.90 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #12 |
Clean Tech | 2 | 2 | Series C | Series C-1 | 46,509,257 | 186.8 | 6/30/2013 | LTM | 2,926 | 7.41 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #13 |
Pharmaceuticals | 1 | 1 | Public | Public | 463,264,000 | 382.7 | 6/30/2013 | LTM | — | 20.00 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #14 |
Pharmaceuticals | 1 | 1 | Series B | Series B | 17,316,986 | 45.6 | 6/30/2013 | LTM | 42,695 | 15.00 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #15 |
Medical Device | 2 | 2 | Series C | Series D | 53,412,629 | 85.3 | 6/30/2013 | LTM | 24,121 | 5.00 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #16 |
Technology | 3 | 3 | Series E | Series E | 129,159,649 | 449.0 | 6/30/2013 | LTM | 4,052 | 13.25 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #17 |
Medical Device | 2 | 3 | Series C | Series C | 59,827,598 | 81.8 | 6/30/2013 | LTM | 43.3 | 9.64 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #18 |
Technology | 2 | 3 | Series C | Series C | 44,339,529 | 133.0 | 6/30/2013 | LTM | 64,061 | 16.39 | 6.63 | ||||||||||||||||||||||||||||
| OBLIGOR #19 |
Pharmaceuticals | 2 | 2 | Series E | Series 1 | 148,121,973 | 55.0 | 6/30/2013 | LTM | 12,385 | 10.00 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #20 |
Medical Device | 2 | 1 | Series C | Series E | 103,031,715 | 175.0 | 6/30/2013 | LTM | 4,952 | 7.25 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #21 |
Technology | 1 | 1 | Public | Public | 252,475,000 | 797.6 | 6/30/2013 | LTM | 92,813 | 10.07 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #22 |
Medical Device | 2 | 2 | Series G | Series G | 55,434,043.0 | 76.6 | 6/30/2013 | LTM | 9,072 | 10.00 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #23 |
Technology | 2 | 2 | Series B | Series B | 27,126,237 | 139.19 | 6/30/2013 | LTM | 26,111 | 10.00 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #24 |
Middle Market | 2 | N/A- Paid Off | Other | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | ||||||||||||||||||||||||||||
| OBLIGOR #25 |
Middle Market | 2 | 2 | Other | Other | 12,188,332 | 34.9 | 6/30/2013 | LTM | 21,465 | 12.40 | 4.49 | ||||||||||||||||||||||||||||
| OBLIGOR #26 |
Pharmaceuticals | N/A | 2 | N/A | Public | 1,877,099,000 | 113.1 | 6/30/2013 | LTM | 1,432 | 10.00 | NM | ||||||||||||||||||||||||||||
| OBLIGOR #27 |
Technology | N/A | 2 | N/A | Public | 337,872,000 | 52.1 | 6/30/2013 | LTM | 94,196 | 12.91 | NM | ||||||||||||||||||||||||||||
Page 2
Loan Information as of June 30, 2013
| Per LSA | ||||||||||||||||||||||
| Obligor CODE |
Status (Active - Initial Pool, Active - Substitute) |
Date of Substitution | Cash Yield | Fixed / Floating | Loan Status (Current, Delinquent, Defaulted, Prepaid, Repaid, Repurchased, Substituted) |
Prepayment Date | Prepayment Amount (Principal + Final Payment + Prepayment Penalty + Success Fee) |
Date of Payment Default | Days Past Due | |||||||||||||
| OBLIGOR #1 |
Active - Initial Pool | 8.50 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #3 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #5 |
Active - Initial Pool | 11.90 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #6 |
Active - Initial Pool | 8.88 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #7 |
Active - Initial Pool | 9.55 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #8 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #10 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #11 |
Active - Initial Pool | 9.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #12 |
Active - Initial Pool | 10.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #13 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #14 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #15 |
Active - Initial Pool | 9.95 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #16 |
Active - Initial Pool | 12.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #17 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #18 |
Active - Initial Pool | 10.13 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #18 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #19 |
Active - Initial Pool | 11.65 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #20 |
Active - Initial Pool | 12.95 | % | Fixed | Current | |||||||||||||||||
| OBLIGOR #21 |
Active - Initial Pool | 6.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #21 |
Active - Initial Pool | 8.75 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #22 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #23 |
Active - Initial Pool | 9.50 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #25 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #25 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #26 |
Active - Substitute | 4/3/2013 | 12.50 | % | Floating | Current | ||||||||||||||||
| OBLIGOR #27 |
Active - Substitute | 5/29/2013 | 11.00 | % | Floating | Current | ||||||||||||||||
Page 3
Abbreviated Quarterly Report
On Behalf of Funding Trust 2012-1
For the fiscal quarter ending September 30, 2013
Prepared: December 11, 2013
Table of Contents
| Obligor Credit Information |
2 | |||
| Loan Information |
3 |
Attached:
Monthly Servicer Reports for the three collection periods ending September 4, 2013
Obligor Credit Information
| Data as of 9-30-13 | ||||||||||||||||||||||||||||||||||||||||||||
| Obligor CODE |
Industry Sector |
SubSector |
Credit Score at Closing |
Current Credit Score |
Investment Stage at Closing |
Current Stage (as defined by equity round raised/Public/Other (LMM) |
Equity Raised to Date (in millions) |
Current Valuation (in millions) Post Money (Private), Market Cap (Public), EV (Other) |
Statement Date | Period | LTM Revenues (in thousands) |
Total Senior Debt (in millions) |
TTM/Annualized EBITDA (in thousands) |
|||||||||||||||||||||||||||||||
| OBLIGOR #1 |
Pharmaceuticals | Drug Delivery | 2 | 1 | Public | Public | 209.2 | 454.1 | 9/30/2013 | LTM | 3,570 | 10.52 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #2 |
Pharmaceuticals | Drug Delivery | 2 | N/A- Substituted | Public | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||||
| OBLIGOR #3 |
Clean Tech | Clean Tech | 2 | 2 | Public | Public | 936.4 | 143.0 | 9/30/2013 | LTM | 85,103 | 16.18 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #4 |
Pharmaceuticals | Drug Discovery & Development | 2 | N/A- Substituted | Public | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||||
| OBLIGOR #5 |
Pharmaceuticals | Drug Discovery & Development | 2 | 3 | Public | Public | 495.2 | 106.8 | 9/30/2013 | LTM | 16,501 | 21.73 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #6 |
Technology | Software | 1 | N/A- Substituted | Series E | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||||
| OBLIGOR #7 |
Pharmaceuticals | Drug Discovery & Development | 1 | 1 | Public | Public | 234.6 | 381.7 | 9/30/2013 | LTM | 5,740 | 15.00 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #8 |
Pharmaceuticals | Drug Discovery & Development | 2 | 1 | Public | Public | 152.3 | 249.6 | 9/30/2013 | LTM | — | 14.77 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #9 |
Pharmaceuticals | Biotechnology Tools | 1 | N/A- Paid Off | Series A | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | |||||||||||||||||||||||||||||||
| OBLIGOR #10 |
Technology | Information Services | 3 | 5 | Series A | Series A | 8.0 | 21.5 | 9/30/2013 | LTM | 1,554 | 0.76 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #11 |
Clean Tech | Clean Tech | 2 | 1 | Public | Public | 190.5 | 339.1 | 9/30/2013 | LTM | 223,741 | 9.29 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #12 |
Clean Tech | Clean Tech | 2 | 2 | Series C | Series C-1 | 58.3 | 193.5 | 9/30/2013 | LTM | 2,983 | 6.14 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #13 |
Pharmaceuticals | Drug Discovery & Development | 1 | 1 | Public | Public | 532.5 | 609.0 | 9/30/2013 | LTM | 11,500 | 20.00 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #14 |
Pharmaceuticals | Drug Delivery | 1 | 1 | Series B | Series B | 17.3 | 45.6 | 9/30/2013 | LTM | 50,599 | 14.76 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #15 |
Medical Device | Biotechnology Tools | 2 | 2 | Series C | Series D | 53.4 | 85.6 | 9/30/2013 | LTM | 26,275 | 4.62 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #16 |
Technology | Communications & Networking | 3 | 3 | Series E | Series E | 129.2 | 449.0 | 9/30/2013 | LTM | 3,118 | 11.44 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #17 |
Medical Device | Therapeutic | 2 | 3 | Series C | Series C | 59.8 | 81.8 | 9/30/2013 | LTM | 58 | 8.77 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #18 |
Technology | Internet Consumer & Business Services | 2 | 3 | Series C | Series C | 44.3 | 110.0 | 9/30/2013 | LTM | 60,626 | 14,917.0 | 6,076.0 | |||||||||||||||||||||||||||||||
| OBLIGOR #19 |
Pharmaceuticals | Diagnostic | 2 | N/A- Substituted | Series A | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||||
| OBLIGOR #20 |
Medical Device | Surgical Devices | 2 | 1 | Series C | Series E | 103.0 | 175.0 | 9/30/2013 | LTM | 5,276 | 7.25 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #21 |
Technology | Internet Consumer & Business Services | 1 | 1 | Public | Public | 465.0 | 1,781.1 | 9/30/2013 | LTM | 114,600 | 8.15 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #22 |
Medical Device | Medical Device & Equipment | 2 | 3 | Series G | Series G | 55.4 | 76.6 | 9/30/2013 | LTM | 8,215 | 10.00 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #23 |
Technology | Internet Consumer & Business Services | 2 | 2 | Series B | Series B | 27 | 137.96 | 9/30/2013 | LTM | 26,351 | 10.00 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #24 |
Middle Market | Media/Content/Info | 2 | N/A- Substituted | Other | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||||
| OBLIGOR #25 |
Middle Market | Internet Consumer & Business Services | 2 | 2 | Other | Other | 12.2 | 32.2 | 9/30/2013 | LTM | 21,670 | 11.79 | 3.4 | |||||||||||||||||||||||||||||||
| OBLIGOR #26 |
Pharmaceuticals | Drug Discovery & Development | N/A | 2 | N/A | Public | 1,900.7 | 172.6 | 9/30/2013 | LTM | 1,794 | 10.00 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #27 |
Technology | Electronics & Computer Hardware | N/A | 2 | N/A | Public | 345.6 | 45.9 | 9/30/2013 | LTM | 97,519 | 11.24 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #28 |
Technology | Clean Tech | N/A | 2 | N/A | Series C | 137.0 | 246.4 | 9/30/2013 | LTM | NM | 10.00 | NM | |||||||||||||||||||||||||||||||
| OBLIGOR #29 |
Pharmaceuticals | Drug Discovery & Development | N/A | 2 | N/A | Series C | 46.8 | 236.1 | 9/30/2013 | LTM | NM | 10.00 | NM | |||||||||||||||||||||||||||||||
Page 2
Loan Information as of September 30, 2013
| Per LSA | ||||||||||||||||||||||
| Obligor CODE |
Status (Active - Initial Pool, Active - Substitute) |
Date of Substitution | Cash Yield | Fixed / Floating | Loan Status (Current, Delinquent, Defaulted, Prepaid, Repaid, Repurchased, Substituted) |
Prepayment Date | Prepayment Amount (Principal + Final Payment + Prepayment Penalty + Success Fee) |
Date of Payment Default | Days Past Due | |||||||||||||
| OBLIGOR #1 |
Active - Initial Pool | 8.50 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #3 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #5 |
Active - Initial Pool | 11.90 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #7 |
Active - Initial Pool | 9.55 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #8 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #10 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #11 |
Active - Initial Pool | 9.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #12 |
Active - Initial Pool | 10.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #13 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #14 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #15 |
Active - Initial Pool | 9.95 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #16 |
Active - Initial Pool | 12.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #17 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #18 |
Active - Initial Pool | 10.13 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #18 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #19 |
Inactive - Initial Pool | 10/29/2013 | 11.65 | % | Floating | Substituted | ||||||||||||||||
| OBLIGOR #20 |
Active - Initial Pool | 12.95 | % | Fixed | Current | |||||||||||||||||
| OBLIGOR #21 |
Active - Initial Pool | 6.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #21 |
Active - Initial Pool | 8.75 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #22 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #23 |
Active - Initial Pool | 9.50 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #25 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #25 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||
| OBLIGOR #26 |
Active - Substitute | 4/3/2013 | 12.25 | % | Floating | Current | ||||||||||||||||
| OBLIGOR #27 |
Active - Substitute | 5/29/2013 | 11.00 | % | Floating | Current | ||||||||||||||||
| OBLIGOR #28 |
Active - Substitute | 8/6/2013 | 11.00 | % | Floating | Current | ||||||||||||||||
| OBLIGOR #29 |
Active - Substitute | 10/29/2013 | 11.85 | % | Floating | Current | ||||||||||||||||
Page 3
Abbreviated Quarterly Report
On Behalf of Funding Trust 2012-1
For the fiscal quarter ending December 31, 2013
Prepared: March 14, 2014
Table of Contents
| Obligor Credit Information |
2 | |||
| Loan Information |
3 |
Attached:
Monthly Servicer Reports for the three collection periods ending December 4, 2013
Obligor Credit Information
| Data as of 12-31-13 | ||||||||||||||||||||||||||||||||||||||||||
| Obligor CODE |
Industry Sector |
SubSector |
Credit Score at Closing |
Current Credit Score |
Investment Stage at Closing |
Current Stage (as defined by equity round raised/Public/Other (LMM) |
Equity Raised to Date (in millions) |
Current Valuation (in millions) Post Money (Private), Market Cap (Public), EV (Other) |
Statement Date | Period | LTM Revenues (in thousands) |
Total Senior Debt (in millions) |
TTM/Annualized EBITDA (in thousands) |
|||||||||||||||||||||||||||||
| OBLIGOR #1 |
Pharmaceuticals | Drug Delivery | 2 | N/A- Paid Off | Public | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | |||||||||||||||||||||||||||||
| OBLIGOR #2 |
Pharmaceuticals | Drug Delivery | 2 | N/A- Substituted | Public | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||
| OBLIGOR #3 |
Clean Tech | Clean Tech | 2 | 3 | Public | Public | 936.4 | 111.8 | 12/31/2013 | LTM | 88,249 | 14.6 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #4 |
Pharmaceuticals | Drug Discovery & Development | 2 | N/A- Substituted | Public | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||
| OBLIGOR #5 |
Pharmaceuticals | Drug Discovery & Development | 2 | 3 | Public | Public | 495.2 | 99.4 | 12/31/2013 | LTM | 1,294 | 19.2 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #6 |
Technology | Software | 1 | N/A- Substituted | Series E | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||
| OBLIGOR #7 |
Pharmaceuticals | Drug Discovery & Development | 1 | 1 | Public | Public | 234.6 | 381.7 | 12/31/2013 | LTM | 7,771 | 15.0 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #8 |
Pharmaceuticals | Drug Discovery & Development | 2 | N/A- Paid Off | Public | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | |||||||||||||||||||||||||||||
| OBLIGOR #9 |
Pharmaceuticals | Biotechnology Tools | 1 | N/A- Paid Off | Series A | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | |||||||||||||||||||||||||||||
| OBLIGOR #10 |
Technology | Information Services | 3 | 5 | Series A | Series A | 8.0 | 21.5 | 12/31/2013 | LTM | 3,475 | 0.7 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #11 |
Clean Tech | Clean Tech | 2 | 1 | Public | Public | 193.1 | 357.3 | 12/31/2013 | LTM | 232,846 | 8.7 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #12 |
Clean Tech | Clean Tech | 2 | 2 | Series C | Series C-1 | 58.3 | 199.3 | 12/31/2013 | LTM | 2,181 | 7.9 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #13 |
Pharmaceuticals | Drug Discovery & Development | 1 | 1 | Public | Public | 534.8 | 664.9 | 12/31/2013 | LTM | 11,500 | 20.0 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #14 |
Pharmaceuticals | Drug Delivery | 1 | 1 | Series B | Series B | 17.3 | 45.6 | 12/31/2013 | LTM | 15,305 | 15.0 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #15 |
Medical Device | Biotechnology Tools | 2 | 2 | Series C | Series D | 53.4 | 85.6 | 12/31/2013 | LTM | 31,930 | 4.3 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #16 |
Technology | Communications & Networking | 3 | 2 | Series E | Series A (Recap) | 183.4 | 179.2 | 12/31/2013 | LTM | 2,839 | 10.1 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #17 |
Medical Device | Therapeutic | 2 | 4 | Series C | Series C | 59.8 | 83.6 | 12/31/2013 | LTM | 70 | 7.6 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #18 |
Technology | Internet Consumer & Business Services | 2 | 3 | Series C | Series C | 44.3 | 110.0 | 12/31/2013 | LTM | 59,499 | 13.7 | 6,737 | |||||||||||||||||||||||||||||
| OBLIGOR #19 |
Pharmaceuticals | Diagnostic | 2 | N/A- Substituted | Series A | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||
| OBLIGOR #20 |
Medical Device | Surgical Devices | 2 | 1 | Series C | Series E | 103.0 | 175.0 | 12/31/2013 | LTM | 5,033 | 7.6 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #21 |
Technology | Internet Consumer & Business Services | 1 | N/A- Paid Off | Public | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | N/A- Paid Off | |||||||||||||||||||||||||||||
| OBLIGOR #22 |
Medical Device | Medical Device & Equipment | 2 | 2 | Series G | Series A (Recap) | 64.4 | 85.9 | 12/31/2013 | LTM | 7,617 | 5.7 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #23 |
Technology | Internet Consumer & Business Services | 2 | 2 | Series B | Series B | 27.1 | 138.0 | 12/31/2013 | LTM | 27,206 | 10.0 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #24 |
Middle Market | Media/Content/Info | 2 | N/A- Substituted | Other | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | N/A- Substituted | |||||||||||||||||||||||||||||
| OBLIGOR #25 |
Middle Market | Internet Consumer & Business Services | 2 | 3 | Other | Other | 12.2 | 29.7 | 12/31/2013 | LTM | 20,262 | 12.8 | 2,206 | |||||||||||||||||||||||||||||
| OBLIGOR #26 |
Pharmaceuticals | Drug Discovery & Development | N/A | 2 | N/A | Public | 1,933.3 | 277.9 | 12/31/2013 | LTM | 34,678 | 15.0 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #27 |
Technology | Electronics & Computer Hardware | N/A | 2 | N/A | Public | 345.6 | 43.0 | 12/31/2013 | LTM | 75,651 | 6.0 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #28 |
Technology | Clean Tech | N/A | 2 | N/A | Series C | 140.2 | 246.4 | 12/31/2013 | LTM | NM | 10.0 | NM | |||||||||||||||||||||||||||||
| OBLIGOR #29 |
Pharmaceuticals | Drug Discovery & Development | N/A | 2 | N/A | Series C | 203.1 | 270.9 | 12/31/2013 | LTM | 4,720 | 10.0 | NM | |||||||||||||||||||||||||||||
Page 2
Loan Information as of December 31, 2013
| Per LSA | ||||||||||||||||||||||||||
| Obligor CODE |
Status (Active - Initial Pool, Active - Substitute) |
Date of Substitution | Cash Yield | Fixed / Floating | Loan Status (Current, Delinquent, Defaulted, Prepaid, Repaid, Repurchased, Substituted) |
Prepayment Date | Prepayment Amount (Principal + Final Payment + Prepayment Penalty + Success Fee) |
Date of Payment Default | Days Past Due | |||||||||||||||||
| OBLIGOR #1 |
Inactive - Initial Pool | 8.50 | % | Floating | Prepaid | 12/16/2013 | $ | 4,285,773 | ||||||||||||||||||
| OBLIGOR #2 |
Inactive - Initial Pool | (4/3/2013 | ) | 10.75 | % | Floating | Current | |||||||||||||||||||
| OBLIGOR #3 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #4 |
Inactive - Initial Pool | (4/3/2013 | ) | 10.55 | % | Floating | Current | |||||||||||||||||||
| OBLIGOR #5 |
Active - Initial Pool | 11.90 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #6 |
Inactive - Initial Pool | (8/6/2013 | ) | 8.88 | % | Floating | Substituted | |||||||||||||||||||
| OBLIGOR #7 |
Active - Initial Pool | 9.55 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #8 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #9 |
Inactive - Initial Pool | 13.50 | % | Floating | Prepaid | 12/10/2012 | $ | 3,909,219 | ||||||||||||||||||
| OBLIGOR #10 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #11 |
Active - Initial Pool | 9.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #12 |
Active - Initial Pool | 10.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #13 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #14 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #15 |
Active - Initial Pool | 9.95 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #16 |
Active - Initial Pool | 12.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #17 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #18 |
Active - Initial Pool | 10.13 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #18 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #19 |
Inactive - Initial Pool | (10/29/2013 | ) | 11.65 | % | Floating | Substituted | |||||||||||||||||||
| OBLIGOR #20 |
Active - Initial Pool | 12.95 | % | Fixed | Current | |||||||||||||||||||||
| OBLIGOR #21 |
Inactive - Initial Pool | 6.00 | % | Floating | Prepaid | 12/17/2003 | $ | 3,591,075 | ||||||||||||||||||
| OBLIGOR #21 |
Inactive - Initial Pool | 8.75 | % | Floating | Prepaid | 12/17/2003 | $ | 3,632,341 | ||||||||||||||||||
| OBLIGOR #22 |
Active - Initial Pool | 11.00 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #23 |
Active - Initial Pool | 9.50 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #24 |
Inactive - Initial Pool | (5/29/2013 | ) | 10.00 | % | Floating | Substituted | |||||||||||||||||||
| OBLIGOR #25 |
Active - Initial Pool | 9.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #25 |
Active - Initial Pool | 10.25 | % | Floating | Current | |||||||||||||||||||||
| OBLIGOR #26 |
Active - Substitute | 4/3/2013 | 12.25 | % | Floating | Current | ||||||||||||||||||||
| OBLIGOR #27 |
Active - Substitute | 5/29/2013 | 11.00 | % | Floating | Current | ||||||||||||||||||||
| OBLIGOR #28 |
Active - Substitute | 8/6/2013 | 11.00 | % | Floating | Current | ||||||||||||||||||||
| OBLIGOR #29 |
Active - Substitute | 10/29/2013 | 11.85 | % | Floating | Current | ||||||||||||||||||||
Page 3